- Eli Lilly Stock Rises on Earnings and Boost to Guidance Barron’s
- Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar CNBC
- Eli Lilly raises full-year forecast, as weight-loss drugs demand drives third-quarter beat Yahoo Finance
- Lilly Raises Guidance on Strength of Weight Loss, Obesity Drugs Bloomberg
- Eli Lilly stock pops on raised full-year outlook (LLY:NYSE) Seeking Alpha
Source link
![Apple reports Q4 2025 earnings, here are the numbers [charts] Apple reports Q4 2025 earnings, here are the numbers [charts]](https://i0.wp.com/9to5mac.com/wp-content/uploads/sites/6/2024/12/apple-logo-store.jpg?resize=1200%2C628&quality=82&strip=all&ssl=1)